Takeda Breathes New Life Into Entyvio With Preventative Use In Crohn’s Disease
Takeda’s head of gastroenterology talked to In Vivo about the major’s plans for finding biomarkers for Crohn’s disease as part of a Euro-wide prevention and interception trial.
![](https://insights.citeline.com/resizer/v2/ATV257QDT5DXPBJ6QW3TUYTFTA.jpg?smart=true&auth=98666cd9f3ee6667a3915de444533ec42d3f7dc334463ad00df65d84489a7610&width=700&height=394)